martes, 6 de octubre de 2026
BuscarExplore
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· March 2, 2026

Stock market today: Dow, S&P 500, Nasdaq pare losses while oil prices jump as Wall Street watches Iran fallout

View original at finance.yahoo.com
Stock market today: Dow, S&P 500, Nasdaq pare losses while oil prices jump as Wall Street watches Iran fallout US stocks began to pare losses through late morning trading on Monday while oil prices surged after military strikes by the US and Israel on Iran were followed by counterattacks, sending shockwaves through glo…
Opening lines of the source · short snapshot — read the full document at the original

Lo que extrajimos de esta fuente

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Company doesn't plan to cut production and WBD purchase is pro-competition, pro-consumer and pro-creative community

    80% confidence
  • Trump has agreed to speak with Iran's new leadership

    80% confidence
  • JPMorgan expects a risk premium gain of up to 10% for gold

    80% confidence
  • Calling for Iran's leaders to hand power to the nation's people

    80% confidence
  • Iran conflict unlikely to dent bullish market view

    80% confidence
  • Oil prices could reach $120 per barrel if war spreads throughout Middle East

    80% confidence
  • Bombing against Iran will continue for several weeks

    80% confidence
  • Paramount targeting 15 theatrical films a year per studio for total of at least 30 films annually

    80% confidence
  • Computing has fundamentally changed; in the age of AI, software runs on intelligence with tokens generated in real time by AI factories

    80% confidence
  • Deal expected to close in third quarter with $69 billion in pro-forma revenue, $18 billion in EBITDA, and combined net of $79 billion

    80% confidence
Lo que sabemos · la inteligencia detrás de esta página
En vivo desde el sustrato
Lo que estamos viendo
Obesity and Immunology Readouts, Big Pharma M&A and AI-Designed Drugs Converge Into a Q4 2026 Catalyst Wave
Late-stage data and deal activity are clustering ahead of Q4 2026. Novo Nordisk's CagriSema won Best Abstract at EASD 2026 for its brain and body (fMRI/MRI) data, Lilly showed ADtouch results for EBGLYSS and agreed to buy Merida Biosciences for $2.9B, and Merck's tulisokibart hit its Phase 2b endpoints. A key regulatory catalyst follows: the FDA PDUFA date for the ivonescimab BLA on 2026-11-14. AI-designed rentosertib showing anti-aging effects adds a speculative AI-drug-discovery thread, while QAIAx's microcities trial and QIII pilot (planned 2027-01-01) are peripheral, forecast-only items.
Nuestra lectura de los datos ›
Señales que seguimos
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Patrones que observamos ›
Donde las fuentes discrepan
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
Señalamos los conflictos abiertamente ›
Verificado recientemente
✓ Verificado con la fuente original
4,985
hechos rastreados a su fuente — y señalamos los que no se sostienen.
101 entidades seguidas4,985 hechos verificados con la fuente5,351 documentos fuente archivados
Consulta estos datos → isubstrate.com